CORC

在结果中检索

CORC

浏览/检索结果: 共37条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Li, Yue;  Li, Chong;  Jiang, Ya;  Han, Xue;  Liu, Sisi
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients 期刊论文
THORACIC CANCER, 2021
作者:  Gong, Lei;  He, Ronghui;  Xu, Yanjun;  Luo, Taobo;  Jin, Kaixiu
收藏  |  浏览/下载：38/0  |  提交时间：2021/08/31
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database 期刊论文
OPEN MEDICINE, 2021, 卷号: 16
作者:  Lei, Lei;  Yang, Liu;  Xu, Yang-yang;  Chen, Hua-fei;  Zhan, Ping
收藏  |  浏览/下载：3/0  |  提交时间：2022/12/23
NSCLC  HAL  SEER  survival  
The efficacy of anlotinib in squamous cell carcinoma (SCC) patients with or without hypertension in ALTER0303: Anlotinib as a third-line therapy in patients with advanced non-small cell lung cancer (NSCLC). 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Shi, Jianhua;  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31
Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer 期刊论文
EUROPEAN RADIOLOGY, 2018, 卷号: 28, 期号: 7, 页码: 2772-2778
作者:  Zhu, Xinzhong;  Dong, Di;  Chen, Zhendong;  Fang, Mengjie;  Zhang, Liwen
收藏  |  浏览/下载：37/0  |  提交时间：2018/10/10
Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models 期刊论文
MOLECULAR CANCER THERAPEUTICS, 2018, 卷号: 17, 期号: 4, 页码: 751-762
作者:  Ai, Jing;  Chen, Yi;  Peng, Xia;  Ji, Yinchun;  Xi, Yong
收藏  |  浏览/下载：50/0  |  提交时间：2019/01/08
Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung 会议论文
作者:  Goss, G.;  Cobo, M.;  Lu, S.;  Syrigos, K.;  Lee, K. H.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Afatinib versus erlotinib as second-line treatment of patients (pts) with advanced lung squamous cell carcinoma (SCC): Final analysis of the global phase III LUX-Lung 8 (LL8) trial 期刊论文
ANNALS OF ONCOLOGY, 2018, 卷号: 29
作者:  Cseh, A.;  Felip, E.;  Bender, S.;  Goss, G. D.;  Cobo, M.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
GRK5 functions as an oncogenic factor in non-small-cell lung cancer 期刊论文
Cell Death & Disease, 2018, 期号: 9, 页码: 295
作者:  Meng-Ge Wu;  Li-Ping Jiang;  Yong-Bin Chen;  Qiu-Xia Xiong;  Yong-Chun Zhou
收藏  |  浏览/下载：24/0  |  提交时间：2018/09/20
Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 11
作者:  Goss, G.;  Felip, E.;  Cobo, M.;  Lu, S.;  Syrigos, K.
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace